Navigation Links
Cholesterol-lowering drugs may reduce cardiovascular death in Type 2 diabetes
Date:7/16/2014

WINSTON-SALEM, N.C. July 16, 2014 Heart disease and stroke are the leading causes of death and disability among people with Type 2 diabetes. In fact, at least 65 percent of people with diabetes die from some form of heart disease or stroke, according to the American Heart Association.

However, a new study by researchers at Wake Forest Baptist Medical Center suggests that the use of cholesterol-lowering statins may help prolong the lives of people with diabetic cardiovascular disease.

The study is published in the current online edition of Diabetes Care.

"Although our study was not a clinical trial, it did show that people with diabetes and heart disease can still live quite a few years by taking statins," said Don Bowden, Ph.D., professor of biochemistry at Wake Forest Baptist and lead author of the study.

The research team studied data from 371 patients who had participated in the Diabetes Heart Study. At the beginning of the study, the participants received a CT scan to determine their levels of coronary artery calcium (CAC); a CAC score greater than 1,000 indicates an increased risk for cardiovascular disease (CVD).

The team compared the baseline characteristics of 153 patients who died during an average 8.2 years of follow-up and 218 who survived. The researchers assumed that risk for mortality would be consistently high among the study participants. However, 60 percent were still living after more than eight years.

The use of cholesterol-lowering statins at the baseline exam was the only modifiable risk factor identified to be protective against mortality. The participants taking statins at the beginning of the study had a 50 percent increase of being alive as compared to those who didn't.

Bowden said this highlights the importance of widespread prescription of cholesterol-lowering medications among individuals with Type 2 diabetes who have existing high CVD risk, but added that in previous studies the rates of statins prescribed for diabetic patients have been low.

"These data suggest that cholesterol-lowering medications may be used less than recommended and need to be more aggressively targeted as a critical modifiable risk factor," he said.


'/>"/>

Contact: Marguerite Beck
marbeck@wakehealth.edu
336-716-2415
Wake Forest Baptist Medical Center
Source:Eurekalert

Related medicine news :

1. Taking cholesterol-lowering drugs may also reduce the risk of dying from prostate cancer: Study
2. New assay to spot fake malaria drugs could save thousands of lives
3. The Lancet: New trial suggests cheaper drugs for common heart attack procedure could improve outcomes and save health budgets millions
4. Some aggressive cancers may respond to anti-inflammatory drugs
5. Delivering drugs on cue
6. Among weight loss methods, surgery and drugs achieve highest patient satisfaction
7. Emerging HIV epidemics among people who inject drugs in the Middle East and North Africa
8. Dismisses link between suicidal behaviour and ADHD drugs
9. Chemical strategy hints at better drugs for osteoporosis, diabetes
10. Effective drugs for Parkinsons reduce symptoms of Rett syndrome in mice
11. Mayo Clinic moves small-molecule drugs through blood-brain barrier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2020)... ... February 19, 2020 , ... Drs. Richard Amato, Michael ... of Connecticut, celebrate 30 years of serving Monroe, CT with a “Throwback Special” ... they charged in 1989, only thirty dollars. To further serve their patients, they ...
(Date:2/19/2020)... BOSTON (PRWEB) , ... February 19, 2020 , ... ... , MedTech Start Up Founders Encouraged to Apply to Participate in 2020 Cohort ... the MedTech IGNITE program is now accepting applications from startup founders ...
(Date:2/19/2020)... ... 19, 2020 , ... Nvision Biomedical Technologies , a ... for lower extremities at the American College of Foot and Ankle Surgeons Annual ... Ti Stand-Alone Osteotomy Wedge Fixation System will lead Nvision's innovative showcase. The Trigon ...
(Date:2/16/2020)... ... 16, 2020 , ... Accumen Inc., the leader in healthcare ... The Joint Commission to provide a complimentary series of Patient Blood Management (PBM) ... transfusion safety officers) within U.S. hospitals. , “Accumen’s mission is to ...
(Date:2/15/2020)... Calif. (PRWEB) , ... February 14, 2020 , ... Sister ... webinar series - “BIG MONEY IN ABA”. The series explores the challenges, risks, ... next webinar in the series on March 25, 2020 at: https://bit.ly/2OU6lxg ...
Breaking Medicine News(10 mins):
(Date:2/19/2020)... ... 19, 2020 , ... Global Healthcare Exchange, LLC ... of its annual GHX “Best 50” supply chains in North America. ... ability to demonstrate improved operational performance and drive down costs through supply chain ...
(Date:2/15/2020)... ORLANDO, Fla. (PRWEB) , ... February 14, 2020 , ... ... hygiene) and global sustainability, announced today that its full-service customer portal for hospitality partners ... of soap production by 52% in 2019. This has allowed Clean the World to ...
(Date:2/14/2020)... ... February 14, 2020 , ... Dignitana AB , world ... ., has signed on to sponsor three signature events in 2020 with Susan G. ... Susan G. Komen Race for the Cure® and MORE THAN PINK Walk® events in ...
Breaking Medicine Technology: